Janus Henderson Group
PLRX icon

Janus Henderson Group’s Pliant Therapeutics PLRX Stock Holding History

Janus Henderson Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,251
Closed -$25.3K – 2486
2025
Q1 		$25.3K Hold
17,251
– – ﹤0.01% 2478
2024
Q4 		$227K Hold
17,251
– – ﹤0.01% 2377
2024
Q3 		$193K Hold
17,251
– – ﹤0.01% 2442
2024
Q2 		$185K Sell
17,251
-275
-2% -$3.54K ﹤0.01% 2413
2024
Q1 		$261K Buy
17,526
+1
+0% +$16 ﹤0.01% 2291
2023
Q4 		$317K Sell
17,525
-26
-0.1% -$395 ﹤0.01% 2212
2023
Q3 		$305K Buy
17,551
+2
+0% +$35 ﹤0.01% 2176
2023
Q2 		$318K Buy
17,549
+32
+0.2% +$758 ﹤0.01% 2222
2023
Q1 		$466K Buy
+17,517
New +$499K ﹤0.01% 2060

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Janus Henderson Group's PLRX Position: Q2 2025 in Review

Janus Henderson Group sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 17,251 shares — an estimated $25.3K sold.

Janus Henderson Group first reported a position in PLRX in Q1 2023 and held it in 9 quarters. The position peaked at $466K in Q1 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Janus Henderson Group reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Janus Henderson Group sold 17,251 Pliant Therapeutics shares in Q2 2025, an estimated $25.3K.
  • Janus Henderson Group first reported a position in Pliant Therapeutics in Q1 2023 and held it in 9 quarters.
  • Janus Henderson Group's Pliant Therapeutics position peaked at $466K in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.